united healthcare semaglutide Details of failed studies cast pall on Novo Nordisk's GLP-1 as Alzheimer's treatment Novo Nordisk wins EU approval

GOx, as an enzyme catalyst which catalyzed the conversion of glucose into H 2 O 2 , can produce starvation effect on tumor cells as well as provide raw materials for Fenton-like reactions

Studies Showing the Efficacy of Glucagon-Like Peptide-1 Receptor Agonists In addition to lowering HbA1c, GLP-1 RAs improve traditional cardiovascular disease risk factors such as obesity and hypertension, whilst also exerting anti-inflammatory and anti-atherosclerotic effects, and having positive direct modulatory effects on endothelial function

reduced fine lines, coarse wrinkles, and mottled pigmentation

10.1371/journal.pone.0048543 PLoS One 26 KimJ

Xie A, Hanif S, Ouyang J, Tang Z, Kong N, Kim NY, et al